期刊
CELL METABOLISM
卷 18, 期 6, 页码 871-882出版社
CELL PRESS
DOI: 10.1016/j.cmet.2013.10.014
关键词
-
资金
- Wellcome Trust
- Medical Research Council
- Diabetes UK
- European Union
- NIHR Oxford Biomedical Research Centre
- MRC [MC_UU_12012/3] Funding Source: UKRI
- Medical Research Council [MC_UU_12012/3] Funding Source: researchfish
- Wellcome Trust [095531/Z/11/Z] Funding Source: researchfish
Glucagon, secreted by pancreatic islet a cells, is the principal hyperglycemic hormone. In diabetes, glucagon secretion is not suppressed at high glucose, exacerbating the consequences of insufficient insulin secretion, and is inadequate at low glucose, potentially leading to fatal hypoglycemia. The causal mechanisms remain unknown. Here we show that alpha cell K-ATP-channel activity is very low under hypoglycemic conditions and that hyperglycemia, via elevated intracellular ATP/ADP, leads to complete inhibition. This produces membrane depolarization and voltage-dependent inactivation of the Na+ channels involved in action potential firing that, via reduced action potential height and Ca2+ entry, suppresses glucagon secretion. Maneuvers that increase K-ATP channel activity, such as metabolic inhibition, mimic the glucagon secretory defects associated with diabetes. Low concentrations of the K-ATP channel blocker tolbutamide partially restore glucose-regulated glucagon secretion in islets from type 2 diabetic organ donors. These data suggest that impaired metabolic control of the K-ATP channels underlies the defective glucose regulation of glucagon secretion in type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据